PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
04-Jun-2020 VIVEbiotech collaborates with Xyphos Biosciences for clinical development support of convertibleCAR-T(TM) cell therapy Astellas Pharma Inc
04-Jun-2020 AbbVie at EULAR | New Long-term Data from RINVOQ™ (upadacitinib, 15 mg) Phase 3 Studies in Rheumatoid Arthritis AbbVie
04-Jun-2020 Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX® (daratumumab) for the Treatment of Patients with Multiple Myeloma Genmab A/S
04-Jun-2020 Elixirgen Therapeutics Concludes pre-IND Meeting with FDA for its COVID-19 Vaccine Candidate EXG-5003 Elixirgen Therapeutics, Inc.
04-Jun-2020 Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy Artax Biopharma
04-Jun-2020 Novadoz Pharmaceuticals FDA Approvals of Oseltamivir and Dofetilide Continues the Company's Rise in the Generic Market Novadoz Pharmaceuticals
04-Jun-2020 INOVIO and IVI Partner with Seoul National University Hospital to Start Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine (INO-4800) in South Korea INOVIO Pharmaceuticals, Inc.
04-Jun-2020 Immunovia Intends to Carry Out a Directed Share Issue Through an Accelerated Book Building Process Immunovia AB
04-Jun-2020 Targovax Enters Collaboration With Leidos to add Checkpoint Inhibitor Functionality to ONCOS Viruses Targovax
04-Jun-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration
03-Jun-2020 Marinomed expands into Italy and broadens its portfolio Marinomed
03-Jun-2020 NOVO VENTURES LEADS US$55M SERIES B INVESTMENT IN NODTHERA Novo Holdings A/S
03-Jun-2020 Ervaxx rebrands as Enara Bio to reflect a broader emphasis on the discovery and development of novel TCR-based cancer immunotherapies Enara Bio
03-Jun-2020 Oncodesign establishes strategic alliance with HitGen to strengthen its Integrated Drug Discovery Service (IDDS) named DRIVETM Oncodesign
03-Jun-2020 COVID-19: Swedish company is awarded prestigious grant GAEU Consulting AB
03-Jun-2020 Sarclisa® (isatuximab) approved for the treatment of relapsed/refractory multiple myeloma in the EU1 Sanofi
03-Jun-2020 Helsinn Group announces FDA approval of a new liquid formulation of AKYNZEO® (fosnetupitant/palonosetron) injection in the United States Lugano
03-Jun-2020 The Holistic Reports “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020 The Holistic Report
03-Jun-2020 WORLD MEDICAL COMPOSITES MARKET By Fiber Type Overview And Forecast, 2018-2025. theholisticreports.
03-Jun-2020 Almac Clinical Technologies Introduces SimplifyTM, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up Almac Clinical Technologies